Clinical trial
Effect of Pulsatile IV Insulin Delivery on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes
NCT00361907 is registered in ClinicalTrials.gov with Florida Atlantic University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Pulsatile IV Insulin Delivery on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes
- Lead sponsor
- Florida Atlantic University
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- February 28, 2005
- Completion date
- August 31, 2009
- Enrollment
- 105 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.